Today: 7 February 2026
Subscribe
Browse Category

Mergers & Acquisitions News 25 December 2025 - 28 December 2025

ServiceNow (NOW) Stock Weekend Update: What Wall Street Is Watching After the $7.75B Armis Deal, CEO Contract Extension, and Fresh Analyst Targets

ServiceNow (NOW) Stock Weekend Update: What Wall Street Is Watching After the $7.75B Armis Deal, CEO Contract Extension, and Fresh Analyst Targets

NEW YORK, Dec. 28, 2025, 10:58 a.m. ET — Market closed New York Stock Exchange ServiceNow, Inc. (NYSE: NOW) heads into the final trading stretch of the year with investors still digesting a major strategic pivot: a blockbuster cybersecurity acquisition, a growing list of deals across 2025, and new signals from Wall Street about how much of that M&A premium the market is willing to pay. Reuters+1 With U.S. stock exchanges closed for the weekend and the NYSE core session set to reopen Monday morning, attention is shifting from day-to-day price moves to the key question that will likely shape
28 December 2025
····
ServiceNow (NOW) Stock Today: Analyst Price Targets, Armis Deal Digest, and What to Watch Before Monday’s Open

ServiceNow (NOW) Stock Today: Analyst Price Targets, Armis Deal Digest, and What to Watch Before Monday’s Open

NEW YORK, Dec. 27, 2025, 4:52 p.m. ET — Market closed ServiceNow, Inc. (NYSE: NOW) stock is heading into the final stretch of 2025 with Wall Street balancing two competing narratives: a year-end equity backdrop still hovering near record territory, and company-specific debate over whether ServiceNow’s cybersecurity expansion—led by its planned Armis acquisition—adds durable growth or introduces execution and financing risk. With the New York Stock Exchange closed for the weekend, the latest actionable reference point is Friday’s close. ServiceNow shares finished the Dec. 26 session at $153.89, up 0.85% on the day, after trading between roughly $152.21 and $154.48.
27 December 2025
····
Warner Bros. Discovery Stock (WBD) Weekend Update: Deal-Arbitrage Tension Builds Ahead of Monday’s Open

Warner Bros. Discovery Stock (WBD) Weekend Update: Deal-Arbitrage Tension Builds Ahead of Monday’s Open

NEW YORK, Dec. 27, 2025, 11:09 a.m. ET — Market Closed Warner Bros. Discovery, Inc. (NASDAQ: WBD) — the company behind HBO, Warner Bros. studios and a portfolio of cable networks — heads into the final full week of 2025 with its stock trading less like a traditional media name and more like a live referendum on a high-stakes takeover fight. With U.S. markets closed for the weekend, investors are left to digest a familiar but still fast-moving setup: a signed Netflix agreement that would reshape WBD’s crown-jewel assets, and a rival Paramount Skydance all-cash tender offer that has been
27 December 2025
·······
Global M&A Boom in 2025: Dealmaking Hits $4.5 Trillion as Trump Antitrust Shift Fuels Megadeals and the Warner Bros Bidding War

Global M&A Boom in 2025: Dealmaking Hits $4.5 Trillion as Trump Antitrust Shift Fuels Megadeals and the Warner Bros Bidding War

Wall Street is ending 2025 the way it likes to start a new year: with phones buzzing, lawyers on standby, and bankers quietly admitting that “holiday break” has become more of an aspiration than a schedule. In the final stretch of December alone, $463.6 billion in mergers and acquisitions were announced, according to Dealogic data cited by Reuters—helping turn the year-end lull into one of the busiest dealmaking periods in recent memory. Reuters Behind the surge is a mix of boardroom confidence, buoyant valuations, and an increasingly permissive view of deal risk. But one factor is dominating both headlines and
27 December 2025
·····
Merck Stock (MRK) News and Forecasts: FDA Fast-Track Vouchers, TrumpRx Pricing Deal, and Cidara Acquisition in Focus Ahead of the Next Market Session

Merck Stock (MRK) News and Forecasts: FDA Fast-Track Vouchers, TrumpRx Pricing Deal, and Cidara Acquisition in Focus Ahead of the Next Market Session

As of 2:34 a.m. ET in New York on Saturday, December 27, 2025, U.S. stock markets are closed for the weekend.Merck & Co., Inc. (NYSE: MRK) was last quoted around $106.78, up about 0.33% versus its prior close, based on the latest available pricing feed. With year-end trading under way and liquidity often thinner around the holidays, Merck is heading into the next session with an unusually packed headline stack: policy-driven drug pricing news, FDA review acceleration for two experimental therapies, and portfolio diversification via M&A—all against the backdrop of investors constantly re-litigating the same big question: how Merck replaces
27 December 2025
······
WBD Stock Update: Warner Bros. Discovery Shares Hover Near $29 as Netflix Deal, Paramount Bid, and Antitrust Risk Shape the Trade

WBD Stock Update: Warner Bros. Discovery Shares Hover Near $29 as Netflix Deal, Paramount Bid, and Antitrust Risk Shape the Trade

NEW YORK — Dec. 26, 2025 (9:47 p.m. ET) — Warner Bros. Discovery, Inc. Series A Common Stock (NASDAQ: WBD) is heading into the final trading days of the year with a rare combination of forces driving the price: a signed, headline-grabbing deal for its studios and streaming business, a hostile all-cash counterbid for the whole company, and a regulatory review that could determine whether any of it actually closes. Nasdaq WBD ended Friday’s session at $28.80 after a subdued, post-holiday market day on Wall Street. MarketBeat+1 The broader market backdrop was calm—major U.S. indexes finished fractionally lower on light
27 December 2025
·······
Netflix Stock (NFLX) Today: Shares Tick Higher as Wall Street Weighs Warner Bros. Deal Financing, Regulatory Risk, and Q4 Earnings Ahead

Netflix Stock (NFLX) Today: Shares Tick Higher as Wall Street Weighs Warner Bros. Deal Financing, Regulatory Risk, and Q4 Earnings Ahead

As of 1:05 p.m. ET in New York on Friday, December 26, 2025, Netflix, Inc. (NASDAQ: NFLX) is trading at $94.22, up about 0.6% on the day in a quiet, post-holiday session. The broader tape is mixed: the S&P 500 ETF (SPY) is fractionally lower while the Nasdaq-100 ETF (QQQ) is roughly flat—typical of thin year-end trading where stock-specific headlines can matter more than macro catalysts. Friday’s backdrop is also unusually seasonal: December 26 historically has been one of the market’s more consistently positive calendar days, and it falls inside the “Santa Claus rally” window that traders watch into year-end.
26 December 2025
······
Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

NEW YORK — Friday, December 26, 2025 (9:13 a.m. ET): U.S. stocks are heading into a thin, post‑Christmas trading day, with Wall Street set for a relatively muted open as investors digest a strong 2025 tape and look ahead to 2026 rate and earnings narratives. Reuters In that kind of tape, headline-driven biotech names can swing harder than usual—and ABIVAX Société Anonyme (NASDAQ: ABVX) has been exactly that kind of stock in December: a mix of clinical-trial enthusiasm, index-related positioning, and renewed takeover speculation. As of the latest available quote this morning, ABVX was trading around $145.31 in the premarket,
26 December 2025
······
Anglo American plc Stock (LSE:AAL) on 26 December 2025: Teck Merger Milestones, Copper Rally and Analyst Forecasts

Anglo American plc Stock (LSE:AAL) on 26 December 2025: Teck Merger Milestones, Copper Rally and Analyst Forecasts

December 26, 2025 is one of those awkward “news day without a market day” moments in London: UK markets are shut for Boxing Day, so Anglo American plc stock (LSE:AAL) isn’t trading today. The last reported LSE price on widely followed market pages is 3,012 GBX, as of December 24, 2025, with the stock up about 28.9% over one year. FT Markets Yet the story around Anglo American shares is moving anyway—because the company sits at the intersection of two forces that rarely stay quiet over the holidays: copper prices and mega-deal regulation. Below is a comprehensive roundup of the
26 December 2025
····
BP’s $10.1bn Castrol Deal: Stonepeak Buys 65% Stake as Castrol India Open Offer Sets ₹194.04 Price

BP’s $10.1bn Castrol Deal: Stonepeak Buys 65% Stake as Castrol India Open Offer Sets ₹194.04 Price

December 25, 2025 — BP’s biggest divestment in years is now reshaping more than just its balance sheet. It is also triggering a mandatory shareholder offer in India and pulling private-capital heavyweights deeper into the “hidden infrastructure” of the global economy: industrial lubricants. BP has agreed to sell 65% of Castrol to Stonepeak in a transaction valuing the lubricants business at an enterprise value of about $10.1 billion, while CPP Investments (CPPIB) will invest up to $1.05 billion for an indirect, non-controlling stake. BP will retain 35% in a new joint venture, with the ability to sell that stake after
26 December 2025
·····
Healthcare Stocks Outlook (Dec. 25, 2025): Wegovy Pill Breakthrough, FDA Approvals, and a New Wave of M&A Heading Into 2026

Healthcare Stocks Outlook (Dec. 25, 2025): Wegovy Pill Breakthrough, FDA Approvals, and a New Wave of M&A Heading Into 2026

December 25, 2025 — U.S. markets are closed for Christmas, but healthcare stocks are ending the year with a burst of sector-defining catalysts: a landmark oral GLP‑1 approval for weight loss, multiple FDA green lights that moved biotech names sharply, and a renewed M&A drumbeat as big pharma and rare-disease specialists shop for growth. Below is a detailed, news-driven roundup of the most important healthcare stock headlines, forecasts, and analyst themes investors are digesting as of Dec. 25, 2025—and what they could mean for pharma stocks, biotech stocks, medtech stocks, and health insurance stocks in early 2026. Why healthcare stocks
25 December 2025
····
BP sells 65% of Castrol to Stonepeak in $10.1bn deal as Castrol India open offer follows

BP sells 65% of Castrol to Stonepeak in $10.1bn deal as Castrol India open offer follows

LONDON / NEW YORK — December 25, 2025 — BP has agreed to sell a 65% stake in Castrol to Stonepeak in a transaction valuing the lubricants business at about $10.1 billion, marking one of the oil major’s biggest moves yet in its multi‑year effort to simplify operations, cut debt, and sharpen its strategic focus. London South East While the headline announcement landed on December 24, the story continued to develop on December 25 as attention shifted to what the deal means for BP’s balance sheet, Stonepeak’s bet on a cash‑generative industrial brand, and a required open offer for Castrol
25 December 2025
······
1 2 3 4 … 34

Stock Market Today

Diageo share price slips into the weekend as investors eye Feb. 25 results

Diageo share price slips into the weekend as investors eye Feb. 25 results

7 February 2026
Diageo shares closed down 1.48% at 1,760 pence on Friday, trailing a 0.59% gain in the FTSE 100. An updated analyst consensus points to a 2.0% fall in first-half organic net sales ahead of interim results due Feb. 25. Trading volume was light, and the stock remains over 22% below its 52-week high.
National Grid share price: what to know before London reopens after BoE signal

National Grid share price: what to know before London reopens after BoE signal

7 February 2026
National Grid shares closed at 1,285 pence in London on Friday, up 0.23%. The Bank of England held rates at 3.75% after a close vote, signaling possible cuts if inflation falls. National Grid announced a wireless power transmission study with Space Solar and marked five years of IFA2 interconnector operations. Its U.S. ADR ended at $88.06, up $1.17.
BAE Systems share price rises into weekend — what to watch before Monday’s London open

BAE Systems share price rises into weekend — what to watch before Monday’s London open

7 February 2026
BAE Systems shares closed up 1.2% at 1,879 pence on Friday, tracking gains in European defence stocks. The company’s market value stands near £54.8 billion. Investors await BAE’s full-year results on Feb. 18 for updates on cash returns and orders. GXO Logistics renewed and expanded its contract to support BAE’s Type 26 frigate program in Scotland.
Go toTop